Twareat Medical Care Company (TADAWUL:9627)
9.30
0.00 (0.00%)
Sep 2, 2026, 3:10 PM AST
TADAWUL:9627 Cash Flow Statement
Financials in millions SAR. Fiscal year is January - December.
Millions SAR. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Net Income | -2.62 | -10.32 | 23.51 | 14.17 | 25.43 |
Depreciation & Amortization | 5.86 | 5.22 | 4 | 3.12 | 1.56 |
Loss (Gain) From Sale of Assets | - | - | - | - | -0 |
Provision & Write-off of Bad Debts | 17.32 | 14.8 | 1.03 | 2.46 | 6.07 |
Other Operating Activities | 0.39 | -0.3 | 1.59 | 0.93 | 1.63 |
Change in Accounts Receivable | -48.33 | 0.13 | -27.39 | -14.42 | -2.65 |
Change in Inventory | 4.14 | 1.11 | 0.12 | -0.2 | -0.91 |
Change in Accounts Payable | -5.09 | -2.19 | 5.28 | 2.38 | 2.32 |
Change in Unearned Revenue | -0.19 | -0.1 | -0.3 | 0.64 | - |
Change in Other Net Operating Assets | 2.34 | -2.15 | 0.72 | 0.04 | -2.38 |
Operating Cash Flow | -26.18 | 6.21 | 8.57 | 9.12 | 31.05 |
Operating Cash Flow Growth | - | -27.58% | -5.96% | -70.64% | - |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Capital Expenditures | -11.2 | -12.75 | -6.04 | -7.64 | -12.52 |
Sale of Property, Plant & Equipment | - | - | - | - | 0.03 |
Sale (Purchase) of Intangibles | -0.22 | -0.16 | -0.02 | -0.31 | -0.09 |
Investing Cash Flow | -11.42 | -12.91 | -6.05 | -7.95 | -12.57 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Short-Term Debt Issued | - | 77.42 | 8.41 | 0.88 | - |
Long-Term Debt Issued | - | - | - | - | 1.54 |
Total Debt Issued | 133.73 | 77.42 | 8.41 | 0.88 | 1.54 |
Short-Term Debt Repaid | - | -58.02 | -1.87 | - | -4.31 |
Long-Term Debt Repaid | - | -0.96 | -0.95 | -4.57 | -0.66 |
Total Debt Repaid | -93.59 | -58.98 | -2.82 | -4.57 | -4.97 |
Net Debt Issued (Repaid) | 40.15 | 18.44 | 5.59 | -3.69 | -3.43 |
Common Dividends Paid | -0.05 | -9.99 | -8.1 | -8.24 | -3.2 |
Financing Cash Flow | 40.1 | 8.45 | -2.51 | -11.93 | -6.63 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Net Cash Flow | 2.49 | 1.75 | 0.01 | -10.76 | 11.85 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Free Cash Flow | -37.39 | -6.54 | 2.54 | 1.48 | 18.54 |
Free Cash Flow Growth | - | - | 71.83% | -92.03% | - |
Free Cash Flow Margin | -15.44% | -3.57% | 1.32% | 0.95% | 12.40% |
Free Cash Flow Per Share | -0.94 | -0.16 | 0.06 | 0.04 | - |
Levered Free Cash Flow | -39.28 | -1.72 | -8.43 | -3.39 | - |
Unlevered Free Cash Flow | -37.01 | -0.31 | -8.03 | -3.06 | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Cash Interest Paid | 2.71 | 1.87 | 0.33 | 0.27 | 0.55 |
Change in Working Capital | -47.13 | -3.19 | -21.57 | -11.57 | -3.63 |